Merck KGaA ADR
USUSDMerck KGaA ADR (US:MRK) — Biotechnology: Pharmaceutical Preparations. Número de bolsas en las que cotizan las acciones de la empresa: 6. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.
- Merck KGaA — MRK · XETRA DE Número de registro desconocido
Sobre la empresa
- Sitio web
- merck.com
- Sector
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede central
- RAHWAY, Germany
- Consejero delegado
- Kai Beckmann
- Empleados
- 62 136
- Acciones en circulación
- 2.47 mil M a 2026-07-31
- Capital flotante
- 644.35 M
- Capitalización bursátil
- 67.93 mil M USD
- Insiders
- 0%
- Inversores institucionales
- 0.02%
- Industria (SIC)
- Pharmaceutical Preparations
- Forma jurídica
- XSNP
- ISIN
- US58933Y1055
- LEI
- 4YV9Y5M8S0BRK1RP0397
- Ratio de reparto
- 262%
- FCF
- 16.1 mil M USD52%
- Deuda
- 51.1 mil M USD2.8 a. de FCF
- Racha de dividendos
- 56+ a.
- Beneficios, FCF y dividendos pagados — para los 12 meses hasta 30.06.2026 (el último informe de la compañía).
Descripción
Merck KGaA operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific. The Life Science segment offers products, solutions, and services to academic, research and diagnostic labs, biotech, and pharmaceutical companies, as well as the industrial sector; reagents, consumables, devices, instruments, software, and services for research, production, and testing to lab water instruments, microbiology and biomonitoring products, test assays, analytical reagents, and flow cytometry kits and instruments. This segment also provides traditional and novel therapies, such as ration devices, chromatography resins, single-use systems, process chemicals, and excipients for bioprocessing; contract development, manufacturing and testing services, which supports customers from preclinical phases to commercialization. The Healthcare segment discovers, develops, manufactures, and markets prescription drugs and biopharmaceuticals to the therapeutic areas of oncology, rare diseases, neurology and immunology, fertility, cardiovascular, and metabolic and endocrinological disorders. The Electronics segment offers advanced dielectric and metallic materials; photoresist, anti-reflective coating, and material lithography products; clean and selective etch chemistries; materials for chemical-mechanical planarization; high-purity gases for semiconductor manufacturing; and develops and installs delivery equipment for handling of specialty chemicals and gases for semiconductor manufacturing; develops modulating, creating, engineering, and guiding light; and material solutions in liquid crystals, OLED materials, and photoresists. It has in-licensing agreement with Abbisko Therapeutics Co. Ltd., China on drug candidates for the treatment of tenosynovial giant cell tumor; and strategic partnership with Versant Ventures to advance treatments for rare genetic cardiomyopathies. The company was founded in 1668 and is headquartered in Darmstadt, Germany. Merck KGaA operates as a subsidiary of E. Merck KG.
Bolsas y tickers
| Bolsa | Ticker | Moneda | Precio | Tipo |
|---|---|---|---|---|
| US USA Stocks | MRK secundaria | USD | 142.38 -0.29% | acciones ordinarias |
| LSE London Stock Exchange | 0QAH IOB | USD | 148.65 -0.12% | acciones ordinarias |
| MI Borsa Italiana (Milan) | 1MRKX principal | EUR | 129.56 +3.96% | acciones ordinarias |
| MX Mexican Stock Exchange | MRK secundaria | MXN | 2 690 +6.68% | acciones ordinarias |
| VI Vienna Stock Exchange | MRK secundaria | EUR | 124.84 -2.79% | acciones ordinarias |
| XETRA Xetra | 6MK secundaria | EUR | 129.78 +0.09% | acciones ordinarias |
Dividendos
Merck KGaA ADR (MRK) paga dividendos trimestralmente. En los últimos 12 meses, se pagó 3.4 USD por acción (pagos: 4). Eso representa aproximadamente el 2.39% del precio actual de la acción. Según el historial de pagos, se espera la próxima fecha ex-dividendo alrededor de 15.12.2026. Historial de dividendos ininterrumpido: 56 años.
| Fecha ex | Pago | Importe | % | Tipo | Ticker |
|---|---|---|---|---|---|
| 2026-09-15 | 2026-10-07 | 0.8500 USD | 0.6/2.4 % | trimestral | US:MRK |
| 2026-06-15 | 2026-07-08 | 0.8500 USD | 0.6/2.4 % | trimestral | US:MRK |
| 2026-03-16 | 2026-04-07 | 0.8500 USD | 0.6/2.3 % | trimestral | US:MRK |
| 2025-12-15 | 2026-01-08 | 0.8500 USD | 0.6/2.3 % | trimestral | US:MRK |
| 2025-09-15 | 2025-10-07 | 0.8100 USD | 0.6/2.3 % | trimestral | US:MRK |
| 2025-06-16 | 2025-07-08 | 0.8100 USD | 0.6/≈2.3 % | trimestral | US:MRK |
| 2025-03-17 | 2025-04-07 | 0.8100 USD | 0.6/≈2.3 % | trimestral | US:MRK |
| 2024-12-16 | 2025-01-08 | 0.8100 USD | 0.6/≈2.3 % | trimestral | US:MRK |
Noticias de esta semana
Aún no hay noticias del sitio web de la empresa.
Principales accionistas
| Titular | Participación | Acciones | Fecha del informe |
|---|---|---|---|
| BlackRock | 9.2% | 227 M | 2026-06-30 |
| Vanguard Capital Managem… | 6.54% | 161.32 M | 2026-06-30 |
| State Street Corporation | 4.88% | 120.41 M | 2026-06-30 |
| Wellington Management Gr… | 3.5% | 86.25 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.18% | 78.41 M | 2026-06-30 |
| Vanguard Portfolio Manag… | 2.75% | 67.74 M | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.59% | 64 M | 2026-06-30 |
| Geode Capital Management… | 2.46% | 60.74 M | 2026-06-30 |
| Charles Schwab Investmen… | 2.2% | 54.37 M | 2026-06-30 |
| Morgan Stanley | 1.97% | 48.64 M | 2026-06-30 |
| FMR, LLC | 1.84% | 45.44 M | 2026-06-30 |
| JPMORGAN CHASE & CO | 1.78% | 43.89 M | 2026-06-30 |
| iShares Trust-iShares Co… | 1.33% | 32.89 M | 2026-08-31 |
| Fidelity Concord Street… | 1.29% | 31.94 M | 2026-07-31 |
| SCHWAB STRATEGIC TRUST-S… | 1.25% | 30.86 M | 2026-05-31 |
| SPDR S&P 500 ETF TRUST-S… | 1.22% | 30.22 M | 2026-08-31 |
| VANGUARD INDEX FUNDS-Van… | 0.95% | 23.51 M | 2026-06-30 |
| SELECT SECTOR SPDR TRT-S… | 0.72% | 17.75 M | 2026-08-31 |
| VANGUARD SPECIALIZED FUN… | 0.65% | 15.95 M | 2026-07-31 |
| VANGUARD SPECIALIZED FUN… | 0.57% | 13.97 M | 2026-07-31 |
| DAVIS ROBERT M (Chief Ex… | ≈0.02% | 450 351 | 2026-04-29 |
| CHATTOPADHYAY SANAT (Off… | ≈0.01% | 200 675 | 2026-04-29 |
| DELUCA RICHARD ROBERT JR… | ≈0% | 110 167 | 2026-08-12 |
| LI DEAN Y (Officer) | ≈0% | 94 431 | 2026-04-29 |
| LITCHFIELD CAROLINE (Chi… | ≈0% | 92 300 | 2026-04-29 |
| ZACHARY JENNIFER L (Gene… | ≈0% | 45 509 | 2026-08-12 |
| GUINDO CHIRFI (Officer) | ≈0% | 36 613 | 2026-08-13 |
| WILLIAMS DAVID MICHAEL (… | ≈0% | 31 716 | 2026-08-05 |
| ROMANELLI JOSEPH EDWARD… | ≈0% | 28 739 | 2026-01-26 |
| OOSTHUIZEN JOHANNES JACO… | ≈0% | 21 895 | 2026-04-29 |
| Trust for Professional M… | 0% | 24 803 | 2026-05-31 |
| Rhumbline Advisers | 0% | 10 919 | 2026-06-30 |
| SP Funds Trust-SP Funds… | 0% | 6 542 | 2026-07-31 |
| Atlas Capital Advisors I… | 0% | 2 467 | 2026-06-30 |
| Gamma Investing LLC | 0% | 2 302 | 2026-06-30 |
| Salomon & Ludwin, LLC | 0% | 356 | 2026-06-30 |
| PNC Financial Services G… | 0% | 2 | 2026-06-30 |
| The Vanguard Group | — | — | — |
